Last edition
News about "oncology contract research organisation (CRO)"
Gyre Therapeutics Appoints Dan Weng to Board of Directors
Gyre Therapeutics, a US-based commercial-stage biopharmaceutical company focused on innovative therapies for organ fibrosis, has announced the appointment of Dr. Dan Weng, former CEO of Medelis, to its Board of Directors.
Oncology Contract Research Organisation (CRO) | 22/08/2025 | By Dineshwori | 204
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members